Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, announces the launch of its new Brainomix 360 Next Generation platform at the International Stroke ...
Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more than 450,000 patients admitted to 107 NHS England hospitals over a 5-year ...
The Food and Drug Administration (FDA) has granted clearance for a new feature in Brainomix’s 360 Stroke solution, allowing physicians to evaluate ischemic core volume from universally available ...
In the United States alone, more than 795,000 people experience a stroke each year, which is about one in every 40 seconds, causing 1 in 6 deaths from cardiovascular disease. Globally, stroke is a ...
Brainomix Ltd. raised £14 million ($18 million) in a series C financing round to expand its AI-powered imaging solution, Brainomix 360 Stroke, into the U.S. market. Funds will also go towards ...
Artificial intelligence (AI) is helping stroke patients in England access vital treatment more quickly, a study has found. The technology aids doctors in identifying major stroke cases within minutes, ...
George Harston, MD, chief medical and innovation officer for Oxford, U.K.-based Brainomix, said the appeal of the company’s technology is fairly simple. In explaining the company’s variety of ...
Our collaboration with Brainomix enhances the ability to quickly and accurately assess patient eligibility for interventions like thrombectomy based on stroke severity.” — Robert Falk, MD, Founder and ...
Artificial intelligence (AI) is helping stroke patients in England access vital treatment more quickly, a study has found. The technology aids doctors in identifying major stroke cases within minutes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results